The efficacy and safety of cilnidipine on mild to moderate essential hypertension: a systematic review and meta-analysis of randomized controlled trials in Chinese patients.
In conclusion, Cilnidipine is a useful agent to treat mild to moderate essential hypertension in China.
PMID: 22746347 [PubMed - indexed for MEDLINE]
Source: Cardiovascular and Hematological Disorders Drug Targets - Category: Drugs & Pharmacology Tags: Cardiovasc Hematol Disord Drug Targets Source Type: research
More News: Cardiology | Cardiovascular | Databases & Libraries | Drugs & Pharmacology | Heart | Hematology | Hypertension | Norvasc | Statistics | Study